Global Impact

Global Impact

Subscribe

Alberta’s biosimilars policy: another significant step towards improving patient access to safe, effective, and high-quality medicines in Canada

Globe

Global Sandoz Press Release about biosimilar Erelzi®

Important update about the Boucherville plant and development center

Recall of Ranitidine medicines

Announcement about Avara

Important update about the Boucherville plant and development center acquired by Avara

Important Announcement: Avara has acquired our plant and development center in Boucherville

Recall of Valsartan

Important Announcement

Sandoz Canada was recently featured in the Montreal Gazette